These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2888671)

  • 21. The effects of D-amphetamine and related drugs on colonic temperatures of rats kept at various ambient temperatures.
    Yehuda S; Wurtman RJ
    Life Sci I; 1972 Sep; 11(18):851-9. PubMed ID: 4656106
    [No Abstract]   [Full Text] [Related]  

  • 22. Differential behavioural effect of quinpirole in neuroleptic-pretreated rats - role of alpha(1)-adrenoceptor.
    Obuchowicz E
    Eur J Pharmacol; 1999 Nov; 384(2-3):101-9. PubMed ID: 10611430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of leu-enkephalin binding by neuroleptics.
    Somoza E; Bazán E; Galindo A
    Neuropsychobiology; 1982; 8(6):297-303. PubMed ID: 6131391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic haloperidol-amphetamine interactions and mesolimbic dopamine.
    Lynch MR; Kuhn HG; Carey RJ
    Neuropsychobiology; 1988; 19(2):97-103. PubMed ID: 3226530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in the thermic response to chlorpromazine in rats exposed prenatally to central nervous system depressants.
    Fujii T; Ohtaki Y; Nakanishi H; Morimoto S; Hayashi K; Yamamoto N
    Neuropharmacology; 1986 Aug; 25(8):845-51. PubMed ID: 3774115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in chlorpromazine induced CNS effects when associated with other neuroleptics and anxiolytics.
    Pérez-Raya MD; Risco S; Navarro C; Jimenez J; Cabo J
    Pharm Acta Helv; 1989; 64(5-6):146-50. PubMed ID: 2569203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of d-amphetamine and haloperidol alone and in combination on milk drinking in rats.
    Foltin RW; Woolverton WL; Schuster CR
    Psychopharmacology (Berl); 1983; 80(4):342-4. PubMed ID: 6414003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonstriatal dopaminergic neurons: Section X. Morphine, amphetamine, and noncataleptogenic neuroleptics: Introduction: morphine, amphetamine, and noncataleptogenic neuroleptics.
    Costa E
    Adv Biochem Psychopharmacol; 1977; 16():557-63. PubMed ID: 18900
    [No Abstract]   [Full Text] [Related]  

  • 29. Direct in vivo electrochemical monitoring of dopamine release in response to neuroleptic drugs.
    Blaha CD; Lane RF
    Eur J Pharmacol; 1984 Feb; 98(1):113-7. PubMed ID: 6143672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
    Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of d-amphetamine and haloperidol on latent inhibition in healthy male volunteers.
    Kumari V; Cotter PA; Mulligan OF; Checkley SA; Gray NS; Hemsley DR; Thornton JC; Corr PJ; Toone BK; Gray JA
    J Psychopharmacol; 1999 Dec; 13(4):398-405. PubMed ID: 10667617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothermia and poikilothermia induced by a kappa-agonist opioid and a neuroleptic.
    Adler MW; Geller EB
    Eur J Pharmacol; 1987 Aug; 140(2):233-7. PubMed ID: 2889606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation and inhibition of the amphetamine stereotypy in rats by neuroleptics and other agents.
    Lal S; Sourkes TL
    Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):289-301. PubMed ID: 4672248
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of antiparkinson drugs and amphetamine on some pharmacological effects of phenothiazine derivatives used as neuroleptics.
    Morpurgo C; Theobald W
    Psychopharmacologia; 1964 Sep; 6(3):178-91. PubMed ID: 5890694
    [No Abstract]   [Full Text] [Related]  

  • 35. A genetic analysis of the hyperthermic response to d-amphetamine in two inbred strains of mice.
    Jori A; Rutczynski M
    Psychopharmacology (Berl); 1978 Oct; 59(2):199-203. PubMed ID: 103123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of 2-(4-ethyl-1-piperazinyl)-4-(fluorophenyl)-5,6,7,8,9, 10-hexahydrocycloocta[b]pyridine (AD-5423) and haloperidol for their pharmacological activities related to antipsychotic efficacy and/or adverse side-effects.
    Noda Y; Kurumiya S; Miura Y; Oka M
    J Pharmacol Exp Ther; 1993 May; 265(2):745-51. PubMed ID: 8098763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of neuroleptics and of combinations of d-amphetamine and neuroleptics on 3H-dopamine uptake by homogenates from rat striatum.
    Del Rio J; Madroñal J
    Eur J Pharmacol; 1976 Oct; 39(2):267-74. PubMed ID: 976322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disruption of primate social behavior by d-amphetamine and cocaine: differential antagonism by antipsychotics.
    Miczek KA; Yoshimura H
    Psychopharmacology (Berl); 1982; 76(2):163-71. PubMed ID: 6123132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circadian variations in response to amphetamine and chlorpromazine in the rat.
    Wolfe GW; Bousquet WF; Schnell RC
    Commun Psychopharmacol; 1977; 1(1):29-37. PubMed ID: 606469
    [No Abstract]   [Full Text] [Related]  

  • 40. Further studies on the neuroleptic profile of manassantin A.
    Rao KV; Puri VN; el-Sawaf HA
    Eur J Pharmacol; 1990 Apr; 179(3):367-76. PubMed ID: 1973109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.